BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2016
View Archived Issues
Zalgen and NowDiagnostics collaborate on infectious disease diagnostic products
Read More
Novartis initiates phase I/II trial of MAK-683 in advanced malignancies
Read More
GlaxoSmithKline updates pipeline progress of third quarter 2016
Read More
FDA issues complete response letter for sarilumab for rheumatoid arthritis
Read More
Bird Rock Bio requests approval for phase I study of namacizumab
Read More
Final court approval for Telesta's plan of arrangement with ProMetic
Read More
EMA validates MAA for avelumab in metastatic Merkel cell carcinoma
Read More
Combination of MEDI-0680 and durvalumab feasible and active in advanced solid malignancies
Read More
KBP Bioscience's antibiotic KBP-7072 evaluated in phase I trial
Read More
Novogen licenses worldwide rights to GDC-0084 from Genentech
Read More
Japan Tobacco and Torii sign license agreement for JTE-052 in Japan
Read More
Philogen's L19TNF granted orphan drug designation in Europe
Read More
Shionogi's cefiderocol demonstrates potential for biothreat pathogens
Read More
Biogen gives update on regulatory applications for nusinersen in E.U., U.S.
Read More
EA Pharma seeks Japanese approval for budesonide rectal foam for ulcerative colitis
Read More
EMA accepts PharmaMar's MAA for plitidepsin
Read More
Astellas to acquire Ganymed
Read More
AstraZeneca exercises option for Japanese commercialization rights to benralizumab
Read More
Eisai seeks Japanese approval of twice-daily Pariet for PPI-resistant reflux esophagitis
Read More
ReViral initiates phase I trial of RV-521 to treat RSV
Read More
GlaxoSmithKline's gepotidacin effective in phase II trial for skin and skin structure infections
Read More
E-2609 begins phase III program for early Alzheimer's disease
Read More
AbbVie discloses novel TNF-alpha modulators
Read More
Hawaii Biotech describes new Botulinum neurotoxin type A light chain inhibitors
Read More
MSD files for approval of bezlotoxumab in Japan
Read More
Bayer Pharma identifies new N-lysine methyltransferase SMYD2 inhibitors
Read More
Bristol-Myers Squibb presents novel indoleamine 2,3-dioxygenase inhibitors
Read More
Pfizer submits application in Japan for palbociclib
Read More
Catabasis Pharmaceuticals describes novel treatment for cystic fibrosis
Read More